These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37305537)

  • 1. Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy.
    Wang X; Yin G; Zhang W; Song K; Zhang L; Guo Z
    Front Pharmacol; 2023; 14():1220144. PubMed ID: 37305537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin Reductase 1 as a Potential Therapeutic Target for Cancer Therapy.
    Wang X; Yin G; Zhang W; Song K; Zhang L; Guo Z
    Front Pharmacol; 2021; 12():717730. PubMed ID: 34421612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prostaglandin reductase 1 (PTGR1) on gastric carcinoma using lentivirus-mediated system.
    Yang S; Luo F; Wang J; Mao X; Chen Z; Wang Z; Guo F
    Int J Clin Exp Pathol; 2015; 8(11):14493-9. PubMed ID: 26823768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum: Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
    Zhang Q; Chen W; Lv X; Weng Q; Chen M; Cui R; Liang G; Ji J
    Front Pharmacol; 2022; 13():806724. PubMed ID: 35899109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of prostaglandin reductase 1 (PTGR1) suppresses prostate cancer cell proliferation by inducing cell cycle arrest and apoptosis.
    Xue L; Zhu Z; Wang Z; Li H; Zhang P; Wang Z; Chen Q; Chen H; Chong T
    Biosci Trends; 2016 May; 10(2):133-9. PubMed ID: 27150108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of human prostaglandin reductase 1 improves the efficacy of hydroxymethylacylfulvene, an antitumor chemotherapeutic agent.
    Yu X; Erzinger MM; Pietsch KE; Cervoni-Curet FN; Whang J; Niederhuber J; Sturla SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):426-33. PubMed ID: 22895897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents.
    Ladin DA; Soliman E; Griffin L; Van Dross R
    Front Pharmacol; 2021; 12():732903. PubMed ID: 34335283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Lim S; Song G; Kwak HJ; Um JY
    Front Pharmacol; 2019; 10():541. PubMed ID: 31191303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy.
    Luo HY; Shen HY; Perkins RS; Wang YX
    Front Pharmacol; 2023; 14():1200491. PubMed ID: 37124214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corrigendum: Mechanism and Management of Fentanyl-Induced Cough.
    Chen R; Tang LH; Sun T; Zeng Z; Zhang YY; Ding K; Meng QT
    Front Pharmacol; 2020; 11():629157. PubMed ID: 33362568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.
    Huang Z; Chen H; Wang S; Wei H; Wang X; Shen R; Wang Y; Lin R; Lin J
    Front Pharmacol; 2021; 12():753231. PubMed ID: 34539420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum: Role of selective histone deacetylase 6 inhibitor ACY-1215 in cancer and other human diseases.
    Li J; Yu M; Fu S; Liu D; Tan Y
    Front Pharmacol; 2022; 13():1117936. PubMed ID: 36588693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
    Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
    Front Pharmacol; 2023; 14():1207589. PubMed ID: 37205914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum: Research advances in drug therapy of endometriosis.
    Shi J; Tan X; Feng G; Yuan Z; Jiang Z; Banda S; Wang L; Zheng W; Chen L; Yu D; Guo C
    Front Pharmacol; 2023; 14():1274946. PubMed ID: 37680721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum: Research advances in drug therapy of endometriosis.
    Shi J; Tan X; Feng G; Zhuo Y; Jiang Z; Banda S; Wang L; Zheng W; Chen L; Yu D; Guo C
    Front Pharmacol; 2023; 14():1254518. PubMed ID: 37521488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum: Molecular Docking as a Therapeutic Approach for Targeting Cancer Stem Cell Metabolic Processes.
    Arjmand B; Kokabi Hamidpour S; Alavi-Moghadam S; Yavari H; Shahbazbadr A; Rezaei-Tavirani M; Gilany K; Larijani B
    Front Pharmacol; 2022; 13():892656. PubMed ID: 35586055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum: A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth.
    Saran U; Chandrasekaran B; Tyagi A; Shukla V; Singh A; Sharma AK; Damodaran C
    Front Pharmacol; 2024; 15():1420266. PubMed ID: 38860169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy.
    Zhang Y; Sheng Z; Xiao J; Li Y; Huang J; Jia J; Zeng X; Li L
    Front Pharmacol; 2023; 14():1345663. PubMed ID: 38155900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Anakinra Therapy for Non-cancer Inflammatory Diseases.
    Cavalli G; Dinarello CA
    Front Pharmacol; 2019; 10():148. PubMed ID: 30906259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum: Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis.
    Huang G; Huang S; Cui H
    Front Pharmacol; 2022; 13():1117317. PubMed ID: 36588674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.